According to a recently published report, the global Botanical And Plant Drugs Market is expected to grow at the CAGR of 6.8% during 2015-2022. The segmentation of global botanical and plant drugs market is based on therapeutic and geography. The report on Global botanical and plant drugs market forecast, 2015-2022 (by therapeutic and geography) provides detailed overview and predictive analysis of the market.
Full report available Global botanical and plant drugs market forecast, 2015-2022 (by therapeutic and geography)report at http://www.briskinsights.com/report/botanical-and-plant-derived-drug-market
Increasing demand for homeopathic and ayurvedic medicines for the cure of various chronic diseases are expected to boost the global botanical and plant derived drug market during the forecasted period of the study. The increasing demand in the health care industry for botanical drugs is also anticipated to have a significant impact on the growth of botanical drug market. Technological advancements in production process and increasing prevalence of chronic diseases have also contributed significantly towards the growth of these drugs. Some of the challenges faced by the global botanical and plant drugs market are low awareness level among the people and availability of alternative substitutes. This results in highly competitive scenario in the drugs market.
Scope of the report
1. Global botanical and plant drugs market by therapeutic applications, 2012 – 2022 ($ billion)
1.1. Hormone diseases
1.2. Infectious diseases
1.3. Pain and central nervous system disorder
1.4. Cardiovascular and metabolic diseases
1.5. Respiratory and oncology diseases
2. Global botanical and plant drugs market by types of plant drugs, 2012 – 2022 ($ billion)
3. Global high performance ceramic coatings regional outlook, 2012-2022(in $billion)
3.1. North America
3.3. Asia Pacific
3.4. Middle East & Africa
3.5. Latin America
4. Company profiles
4.1. Abbott Laboratories
4.2. Bayer Healthcare
4.4. Bristol Myers
4.5. Eli Lilly
4.7. Glenmark Pharmaceuticals Ltd.
4.8. Johnson And Johnson
4.9. Lupin Ltd.
4.11. Novartis International AG
4.13. Piramal Phytocare Ltd.
4.14. Ranbaxy Laboratories Ltd.
4.15. Tasly Pharmaceuticals Inc.
Release ID: 1653